| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785362 | Brachytherapy | 2018 | 11 Pages |
Abstract
TG-43- and ACE-calculated and film-measured doses were found to agree above the skull layer of the phantom, which is where the tumor would be located in a clinical case. ACE appears to underestimate the attenuation through bone relative to that measured by film; however, the dose to bone is below tolerance levels for this treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Brie Cawston-Grant, Hali Morrison, Ron S. Sloboda, Geetha Menon,